Raimunda S.S. Azevedo, Eliana V.P. Silva, Valéria L. Carvalho, Sueli G. Rodrigues, Joaquim P. Nunes Neto, Hamilton A.O. Monteiro, Victor S. Peixoto, Jannifer O. Chiang, Márcio R.T. Nunes, and Pedro F.C. Vasconcelos
Author affiliations: Instituto Evandro Chagas, Ananindeua, Brazil (R.S.S. Azevedo, E.V.P. Silva, V.L. Carvalho, S.G. Rodrigues, J.P. Nunes Neto, H.A.O. Monteiro, J.O. Chiang, M.R.T. Nunes, P.F.C. Vasconcelos); Universidade do Estado do Pará, Belém, Brazil (V.S. Peixoto, P.F.C. Vasconcelos)
Figure 1. A) Prevalence of immunoglobulin (Ig) M against Mayaro virus in the studied population. B) Prevalence of IgM against Marayo virus according to area of residence. C) Patient sex. D) Patient work activities.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.